Functionally, SLC6A14 substantially enhanced cell proliferation, prevented cell apoptosis, and worsened metastasis of CRC cells in vitro via enhancement of the JAK2/STAT3 Pathway. The gene discussed is JAK2; the disease is colorectal carcinoma.